NCT03168815View on ClinicalTrials.gov

Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy

NAActive, not recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
ImmunocompromisedHematologic MalignancyPost Hematopoietic Stem Cell TransplantHypoxiaPulmonary Infiltrates
Interventions
DEVICE

High Flow Nasal Cannula or Low Flow Nasal Cannula

HFNC vs LFNC

Trial Locations (1)

M5G 1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

Mount Sinai Hospital, Canada

OTHER

NCT03168815 - Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy | Biotech Hunter | Biotech Hunter